Skip to main content
Clinical Trials/DRKS00032898
DRKS00032898
Completed
Not Applicable

Safety of anthelmintic medication during pregnancy: An evaluation of pregnancy outcomes based on the Embryotox cohort

Pharmakovigilanz- und Beratungszentrum für Embryonaltoxikologie Charité – Universitätsmedizin Berlin0 sites323 target enrollmentMarch 4, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Q89.9
Sponsor
Pharmakovigilanz- und Beratungszentrum für Embryonaltoxikologie Charité – Universitätsmedizin Berlin
Enrollment
323
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 4, 2024
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
Female

Investigators

Sponsor
Pharmakovigilanz- und Beratungszentrum für Embryonaltoxikologie Charité – Universitätsmedizin Berlin

Eligibility Criteria

Inclusion Criteria

  • Contact with Embryotox Center of Clinical Teratology and Drug Safety in Pregnancy, Berlin for consultation in pregnancy during the study period (01\.01\.2000 \- 28\.02\.2023\) and exposure to study medication during pregnancy.
  • At first contact with Embryotox Center of Clinical Teratology and Drug Safety in Pregnancy, the pregnancy outcome is unknown and there are no reported pathological findings. Information on pregnancy outcome is completed; quality of information/data must meet internal standards.

Exclusion Criteria

  • Non\-plausible or missing relevant data.

Outcomes

Primary Outcomes

Not specified

Similar Trials